Search clinical trials for: Ibrance
Total 158 results
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
SanofiTerminatedBreast CancerUnited States, Russian Federation, Italy, Australia, Belgium, France, Japan, Ukraine, Netherlands, Argentina, Canada, Portugal, Spain, Austria, Brazil, Bulgaria, Chile, China, Czechia, Finland, Georgia, Germany, Hungary, Korea, Republic... and more
-
Kathryn GoldPfizerActive, not recruitingHead and Neck Squamous Cell CarcinomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Metastatic Breast CarcinomaUnited States
-
University of Colorado, DenverPfizer; Criterium, Inc.; Cascadian Therapeutics Inc.CompletedBreast CancerUnited States
-
PfizerCompleted
-
Emory UniversityNational Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)CompletedSarcoma | Head and Neck Cancer | Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Colorectal Cancer | Ovarian Cancer | Bladder Cancer | Stage IV Non-Small Cell Lung Cancer | Stage III Pancreatic Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer and other conditionsUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
University Hospital HeidelbergGerman Cancer Research Center; National Center for Tumor Diseases, Heidelberg; German Cancer AidCompleted
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Bradley A. McGregor, MDPfizerWithdrawnAdvanced Clear Cell Renal Cell CarcinomaUnited States
-
Icahn School of Medicine at Mount SinaiNYU Langone Health; Weill Medical College of Cornell University; Herbert Irving...Active, not recruitingAnastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastBreast Neoplasms | Breast DiseasesUnited States
-
University of ArizonaPfizerCompletedBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | Recurrent Breast Cancer | HER2 Positive Breast Carcinoma | Breast Cancer StageUnited States
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
ETOP IBCSG Partners FoundationPfizer; Hoffmann-La RocheCompletedBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorFrance, Switzerland, Belgium, Italy
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States, Canada
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
Jules Bordet InstituteCompleted
-
Rush University Medical CenterCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
University Hospital HeidelbergCompleted
-
PfizerCompletedHR+/HER2- Locally Advanced, Metastatic Breast CancerUnited Kingdom
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Dana-Farber Cancer Institute1 Million 4 Anna Foundation; Carson Sarcoma Foundation; Teaming up to Fight Childhood... and other collaboratorsCompleted
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
Dana-Farber Cancer InstitutePfizerCompletedBreast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)TerminatedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditionsUnited States
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Hospital San Carlos, MadridCompleted
-
PfizerCompletedBreast CancerAustralia, India
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
Hoffman OncologyDSCS CROActive, not recruiting
-
PfizerCompletedAdvanced Breast Cancer FemaleMexico, Argentina, Brazil, Colombia
-
Emory UniversityNational Cancer Institute (NCI)WithdrawnPrognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast Carcinoma | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
Washington University School of MedicinePfizer; Rising Tide FoundationTerminatedBreast Cancer | Breast Carcinoma | Cancer of BreastUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Estrogen Receptor Positive TumorSweden
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedCCND1 Gene Amplification | CCND2 Gene Amplification | CCND3 Gene Amplification | CDK4 Gene Amplification | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
PfizerCelgeneCompletedMetastatic Pancreatic Ductal AdenocarcinomaUnited States, Spain
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
University of Michigan Rogel Cancer CenterJohns Hopkins University; Washington University School of Medicine; Northwestern... and other collaboratorsCompletedProstate CancerUnited States
-
St. Jude Children's Research HospitalPfizerTerminatedAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
Istituti Clinici Scientifici Maugeri SpACompletedFemale | Neoplasm Malignant | BreastItaly
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive TumorSweden
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
Spanish Breast Cancer Research GroupAstraZenecaActive, not recruitingBreast NeoplasmsSpain, Ireland